New promising Combo therapy in inflammatory bowel diseases refractory to Anti-TNF agents

Cyclosporine plus vedolizumab

Kata Szántó, T. Molnár, Klaudia Farkas

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)629
Number of pages1
JournalJournal of Crohn's and Colitis
Volume12
Issue number5
DOIs
Publication statusPublished - Apr 27 2018

Fingerprint

Inflammatory Bowel Diseases
Cyclosporine
Therapeutics
vedolizumab

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New promising Combo therapy in inflammatory bowel diseases refractory to Anti-TNF agents : Cyclosporine plus vedolizumab. / Szántó, Kata; Molnár, T.; Farkas, Klaudia.

In: Journal of Crohn's and Colitis, Vol. 12, No. 5, 27.04.2018, p. 629.

Research output: Contribution to journalLetter

@article{be45926c67e640cd9e69d75cb00b725c,
title = "New promising Combo therapy in inflammatory bowel diseases refractory to Anti-TNF agents: Cyclosporine plus vedolizumab",
author = "Kata Sz{\'a}nt{\'o} and T. Moln{\'a}r and Klaudia Farkas",
year = "2018",
month = "4",
day = "27",
doi = "10.1093/ecco-jcc/jjx179",
language = "English",
volume = "12",
pages = "629",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - New promising Combo therapy in inflammatory bowel diseases refractory to Anti-TNF agents

T2 - Cyclosporine plus vedolizumab

AU - Szántó, Kata

AU - Molnár, T.

AU - Farkas, Klaudia

PY - 2018/4/27

Y1 - 2018/4/27

UR - http://www.scopus.com/inward/record.url?scp=85046538519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046538519&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjx179

DO - 10.1093/ecco-jcc/jjx179

M3 - Letter

VL - 12

SP - 629

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 5

ER -